Complement C3 in combination with A1-microglobulin (A1M), A2-macroglobulin (A2M) reported high accuracy in panels for discriminating between AD and healthy individuals, whereas Aβ42 and BDNF were found in combination with various biomarkers in the studies. This evidence concerns the gene BDNF and Alzheimer disease.